메뉴 건너뛰기




Volumn 20, Issue 7, 2014, Pages 1187-1193

Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis: A prospective study

Author keywords

Chromoendoscopy; Fecal calprotectin; Narrow band imaging; Predictor; Relapse; Ulcerative colitis

Indexed keywords

ALBUMIN; AZATHIOPRINE; C REACTIVE PROTEIN; CALGRANULIN; HEMOGLOBIN; MESALAZINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; BIOLOGICAL MARKER;

EID: 84905508939     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000069     Document Type: Article
Times cited : (56)

References (34)
  • 1
    • 84861338466 scopus 로고    scopus 로고
    • Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study
    • Meucci G, Fasoli R, Saibeni S, et al. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study. Inflamm Bowel Dis. 2012;18:1006-1010.
    • (2012) Inflamm Bowel Dis. , vol.18 , pp. 1006-1010
    • Meucci, G.1    Fasoli, R.2    Saibeni, S.3
  • 2
    • 79957452795 scopus 로고    scopus 로고
    • Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis
    • e483
    • Ardizzone S, Cassinotti A, Duca P, et al. Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis. Clin Gastroenterol Hepatol. 2011;9:483-489. e483.
    • (2011) Clin Gastroenterol Hepatol. , vol.9 , pp. 483-489
    • Ardizzone, S.1    Cassinotti, A.2    Duca, P.3
  • 3
    • 34547503869 scopus 로고    scopus 로고
    • Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
    • Froslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133:412-422.
    • (2007) Gastroenterology , vol.133 , pp. 412-422
    • Froslie, K.F.1    Jahnsen, J.2    Moum, B.A.3
  • 4
    • 70349418632 scopus 로고    scopus 로고
    • Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab
    • quiz 1520
    • Sandborn WJ, Rutgeerts P, Feagan BG, et al. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. 2009;137:1250-1260. quiz 1520.
    • (2009) Gastroenterology , vol.137 , pp. 1250-1260
    • Sandborn, W.J.1    Rutgeerts, P.2    Feagan, B.G.3
  • 5
    • 67049137968 scopus 로고    scopus 로고
    • Clinical course during the first 10 years of ulcerative colitis: Results from a population-based inception cohort (IBSEN Study)
    • Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431-440.
    • (2009) Scand J Gastroenterol. , vol.44 , pp. 431-440
    • Solberg, I.C.1    Lygren, I.2    Jahnsen, J.3
  • 6
    • 0026065160 scopus 로고
    • Microscopic activity in ulcerative colitis: What does it mean?
    • Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis: what does it mean? Gut. 1991;32:174-178.
    • (1991) Gut , vol.32 , pp. 174-178
    • Riley, S.A.1    Mani, V.2    Goodman, M.J.3
  • 7
    • 10744221150 scopus 로고    scopus 로고
    • Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
    • Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
    • (2004) Gastroenterology , vol.126 , pp. 451-459
    • Rutter, M.1    Saunders, B.2    Wilkinson, K.3
  • 8
    • 80053130407 scopus 로고    scopus 로고
    • Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis
    • Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141:1194-1201.
    • (2011) Gastroenterology , vol.141 , pp. 1194-1201
    • Colombel, J.F.1    Rutgeerts, P.2    Reinisch, W.3
  • 9
    • 34848893583 scopus 로고    scopus 로고
    • Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study
    • quiz 1340-1091
    • Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099-1105. quiz 1340-1091.
    • (2007) Gastroenterology , vol.133 , pp. 1099-1105
    • Gupta, R.B.1    Harpaz, N.2    Itzkowitz, S.3
  • 10
    • 0033013167 scopus 로고    scopus 로고
    • Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease
    • Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34:50-54.
    • (1999) Scand J Gastroenterol. , vol.34 , pp. 50-54
    • Roseth, A.G.1    Schmidt, P.N.2    Fagerhol, M.K.3
  • 11
    • 0033795259 scopus 로고    scopus 로고
    • A simple method for assessing intestinal inflammation in Crohn's disease
    • Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000;47:506-513.
    • (2000) Gut , vol.47 , pp. 506-513
    • Tibble, J.1    Teahon, K.2    Thjodleifsson, B.3
  • 12
    • 14544308315 scopus 로고    scopus 로고
    • Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
    • Costa F, Mumolo MG, Ceccarelli L, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut. 2005;54:364-368.
    • (2005) Gut , vol.54 , pp. 364-368
    • Costa, F.1    Mumolo, M.G.2    Ceccarelli, L.3
  • 13
    • 0034234796 scopus 로고    scopus 로고
    • Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
    • Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;119:15-22.
    • (2000) Gastroenterology , vol.119 , pp. 15-22
    • Tibble, J.A.1    Sigthorsson, G.2    Bridger, S.3
  • 14
    • 49349114912 scopus 로고    scopus 로고
    • Can calprotectin predict relapse risk in inflammatory bowel disease?
    • D'Inca R, Dal Pont E, Di Leo V, et al. Can calprotectin predict relapse risk in inflammatory bowel disease? Am J Gastroenterol. 2008;103:2007-2014.
    • (2008) Am J Gastroenterol. , vol.103 , pp. 2007-2014
    • D'Inca, R.1    Dal Pont, E.2    Di Leo, V.3
  • 15
    • 70349484242 scopus 로고    scopus 로고
    • Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
    • Gisbert JP, Bermejo F, Perez-Calle JL, et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis. 2009;15:1190-1198.
    • (2009) Inflamm Bowel Dis. , vol.15 , pp. 1190-1198
    • Gisbert, J.P.1    Bermejo, F.2    Perez-Calle, J.L.3
  • 16
    • 77952104443 scopus 로고    scopus 로고
    • Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    • Garcia-Sanchez V, Iglesias-Flores E, Gonzalez R, et al. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? J Crohns Colitis. 2010;4:144-152.
    • (2010) J Crohns Colitis. , vol.4 , pp. 144-152
    • Garcia-Sanchez, V.1    Iglesias-Flores, E.2    Gonzalez, R.3
  • 17
    • 84862524860 scopus 로고    scopus 로고
    • Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
    • D'Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2218-2224.
    • (2012) Inflamm Bowel Dis. , vol.18 , pp. 2218-2224
    • D'Haens, G.1    Ferrante, M.2    Vermeire, S.3
  • 18
    • 63649130839 scopus 로고    scopus 로고
    • Mucosal vascular pattern in ulcerative colitis: Observations using narrow band imaging colonoscopy with special reference to histologic inflammation
    • Kudo T, Matsumoto T, Esaki M, et al. Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation. Int J Colorectal Dis. 2009;24:495-501.
    • (2009) Int J Colorectal Dis. , vol.24 , pp. 495-501
    • Kudo, T.1    Matsumoto, T.2    Esaki, M.3
  • 19
    • 0030670836 scopus 로고    scopus 로고
    • Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis
    • Matsumoto T, Kuroki F, Mizuno M, et al. Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis. Gastrointest Endosc. 1997;46:400-405.
    • (1997) Gastrointest Endosc. , vol.46 , pp. 400-405
    • Matsumoto, T.1    Kuroki, F.2    Mizuno, M.3
  • 20
    • 0036781083 scopus 로고    scopus 로고
    • Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis
    • Fujiya M, Saitoh Y, Nomura M, et al. Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis. Gastrointest Endosc. 2002;56:535-542.
    • (2002) Gastrointest Endosc. , vol.56 , pp. 535-542
    • Fujiya, M.1    Saitoh, Y.2    Nomura, M.3
  • 21
    • 79955577193 scopus 로고    scopus 로고
    • Endoscopic findings under narrow band imaging colonoscopy in ulcerative colitis
    • Esaki M, Kubokura N, Kudo T, et al. Endoscopic findings under narrow band imaging colonoscopy in ulcerative colitis. Dig Endosc. 2011;23(suppl 1):140-142.
    • (2011) Dig Endosc. , vol.23 , Issue.SUPPL. 1 , pp. 140-142
    • Esaki, M.1    Kubokura, N.2    Kudo, T.3
  • 22
    • 33845463326 scopus 로고    scopus 로고
    • Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis
    • Nishio Y, Ando T, Maeda O, et al. Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis. Gut. 2006;55:1768-1773.
    • (2006) Gut , vol.55 , pp. 1768-1773
    • Nishio, Y.1    Ando, T.2    Maeda, O.3
  • 23
    • 0023521441 scopus 로고
    • Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study
    • Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-1629.
    • (1987) N Engl J Med. , vol.317 , pp. 1625-1629
    • Schroeder, K.W.1    Tremaine, W.J.2    Ilstrup, D.M.3
  • 24
    • 73049175547 scopus 로고
    • The value of rectal biopsy in the diagnosis of ulcerative colitis
    • Matts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med. 1961;30:393-407.
    • (1961) Q J Med. , vol.30 , pp. 393-407
    • Matts, S.G.1
  • 25
    • 0035166741 scopus 로고    scopus 로고
    • Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
    • Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001;120:13-20.
    • (2001) Gastroenterology , vol.120 , pp. 13-20
    • Bitton, A.1    Peppercorn, M.A.2    Antonioli, D.A.3
  • 26
    • 33646778482 scopus 로고    scopus 로고
    • The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications
    • Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
    • (2006) Gut , vol.55 , pp. 749-753
    • Satsangi, J.1    Silverberg, M.S.2    Vermeire, S.3
  • 27
    • 0037379754 scopus 로고    scopus 로고
    • Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis
    • Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124:880-888.
    • (2003) Gastroenterology , vol.124 , pp. 880-888
    • Kiesslich, R.1    Fritsch, J.2    Holtmann, M.3
  • 28
    • 79955555545 scopus 로고    scopus 로고
    • The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease
    • e1812
    • Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology. 2011;140:1817-1826. e1812.
    • (2011) Gastroenterology , vol.140 , pp. 1817-1826
    • Lewis, J.D.1
  • 29
    • 72549104759 scopus 로고    scopus 로고
    • Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes
    • Schoepfer AM, Beglinger C, Straumann A, et al. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis. 2009;15:1851-1858.
    • (2009) Inflamm Bowel Dis. , vol.15 , pp. 1851-1858
    • Schoepfer, A.M.1    Beglinger, C.2    Straumann, A.3
  • 30
    • 57449093379 scopus 로고    scopus 로고
    • Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis
    • Osada T, Ohkusa T, Okayasu I, et al. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. J Gastroenterol Hepatol. 2008;23(suppl 2):S262-S267.
    • (2008) J Gastroenterol Hepatol. , vol.23 , Issue.SUPPL. 2
    • Osada, T.1    Ohkusa, T.2    Okayasu, I.3
  • 31
    • 39849086660 scopus 로고    scopus 로고
    • Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis
    • Xiang JY, Ouyang Q, Li GD, et al. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol. 2008;14:53-57.
    • (2008) World J Gastroenterol. , vol.14 , pp. 53-57
    • Xiang, J.Y.1    Ouyang, Q.2    Li, G.D.3
  • 32
    • 10844282782 scopus 로고    scopus 로고
    • PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
    • Loftus EV Jr, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91-96.
    • (2005) Gut , vol.54 , pp. 91-96
    • Loftus Jr., E.V.1    Harewood, G.C.2    Loftus, C.G.3
  • 33
    • 62949097145 scopus 로고    scopus 로고
    • Narrow-band imaging without optical magnification for histologic analysis of colorectal polyps
    • Rex DK. Narrow-band imaging without optical magnification for histologic analysis of colorectal polyps. Gastroenterology. 2009;136:1174-1181.
    • (2009) Gastroenterology , vol.136 , pp. 1174-1181
    • Rex, D.K.1
  • 34
    • 84862880940 scopus 로고    scopus 로고
    • Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease
    • Kiesslich R, Duckworth CA, Moussata D, et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut. 2012;61:1146-1153.
    • (2012) Gut , vol.61 , pp. 1146-1153
    • Kiesslich, R.1    Duckworth, C.A.2    Moussata, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.